HIV: Causes, Symptoms, Treatment & Prevention

The Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically targeting and damaging the CD4 cells, which are a type of white blood cell crucial for fighting infections. If left untreated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS), a severe and life-threatening condition characterized by a weakened immune system.

1. Introduction to HIV

HIV is a retrovirus, meaning it contains RNA as its genetic material instead of DNA. It replicates by using an enzyme called reverse transcriptase to convert its RNA into DNA, which is then integrated into the host cell’s genome. Once integrated, the virus can remain dormant for years before becoming active again and continuing to replicate and spread throughout the body.

The history of HIV discovery dates back to the early 1980s when cases of a rare lung infection and skin cancer began appearing in clusters among young, previously healthy gay men in the United States. These cases were later recognized as the first documented instances of what would become known as HIV/AIDS.

The HIV lifecycle and replication process involve several key steps: 1 2

1. Binding and Entry: The virus binds to specific receptors on the surface of target cells, such as CD4 cells, and fuses with the cell membrane to gain entry.
2. Reverse Transcription: Once inside the cell, the HIV RNA is reverse transcribed into DNA by the enzyme reverse transcriptase.
3. Integration: The HIV DNA integrates into the host cell’s genome, becoming a provirus.
4. Transcription and Translation: The proviral DNA is transcribed into new viral RNA, and viral proteins are synthesized.
5. Assembly and Budding: New virus particles are assembled and bud off from the host cell membrane, acquiring a lipid envelope during the process.
6. Maturation: The newly formed virus particles undergo a maturation process, becoming infectious and capable of infecting other cells.

2. Causes and Transmission of HIV

HIV is primarily transmitted through the exchange of bodily fluids, such as blood, semen, vaginal fluids, and breast milk. The main modes of transmission are:

• Sexual Contact: HIV can be transmitted through unprotected vaginal, anal, or oral sex with an HIV-positive individual.
• Blood-to-Blood Contact: Sharing needles or other injection equipment with an HIV-positive person, or receiving contaminated blood products or organ transplants.
• Mother-to-Child Transmission: HIV can be passed from an HIV-positive mother to her child during pregnancy, childbirth, or breastfeeding.

Risk factors for HIV infection include having unprotected sex, sharing needles or other injection equipment, receiving contaminated blood products, and being the child of an HIV-positive mother. Certain populations, such as men who have sex with men, intravenous drug users, and sex workers, have a higher risk of HIV exposure. 3

3. Symptoms and Stages of HIV Infection

HIV infection progresses through several stages, each with its own set of symptoms.

Acute HIV Infection (Acute Retroviral Syndrome)

Within 2-4 weeks after initial infection, some individuals may experience flu-like symptoms, known as acute retroviral syndrome. These symptoms can include fever, sore throat, fatigue, muscle aches, and rash. However, many people with HIV may not experience any symptoms during this stage.

Clinical Latency Stage ( Chronic HIV)

After the initial acute infection, HIV enters a chronic or latency stage, during which the virus continues to replicate at low levels. This stage can last for years or even decades without treatment. Some individuals may experience mild, non-specific symptoms such as swollen lymph nodes, fatigue, diarrhea, or weight loss.

Progression to AIDS

If HIV is left untreated, the virus gradually weakens the immune system by depleting the CD4 cells. When the CD4 count drops below a certain level (typically below 200 cells/mm³), individuals become susceptible to opportunistic infections and certain cancers, which are characteristic of the most severe stage of HIV infection, known as Acquired Immunodeficiency Syndrome (AIDS). Symptoms of AIDS can include rapid weight loss, pneumonia, severe and persistent diarrhea, vision loss, and various types of cancers, such as Kaposi’s sarcoma and lymphoma. 4

4. Diagnosis and Testing

HIV is typically diagnosed through a series of blood tests that detect the presence of HIV antibodies or the virus itself. The most common types of HIV tests are:

Antibody Tests

• Enzyme-Linked Immunosorbent Assay (ELISA): This is often the first test used to detect HIV antibodies in the blood. If the ELISA is positive, a confirmatory test, such as a Western blot, is typically performed.
• Rapid Antibody Tests: These tests can provide results in as little as 20 minutes and can be conducted using a finger-prick blood sample or oral fluid sample.

Antigen/ Antibody Tests

These tests detect both HIV antibodies and antigens (proteins from the virus itself), allowing for earlier detection of HIV before antibodies have developed.

Nucleic Acid Tests (NATs)

These highly sensitive tests detect the presence of HIV genetic material (RNA or DNA) in the blood and can identify HIV infection as early as 10-33 days after exposure.

It’s important to note that there is a window period between initial HIV infection and when the tests can reliably detect the virus or antibodies. During this period, which can last up to 3 months, an individual may test negative despite being infected. Therefore, repeat testing is recommended for those with potential exposures. 5

5. Treatment for HIV

While there is no cure for HIV, antiretroviral therapy (ART) is a highly effective treatment that can suppress the virus and allow individuals with HIV to lead long, healthy lives. ART involves a combination of three or more antiretroviral drugs from different classes, such as:

• Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
• Protease Inhibitors (PIs)
• Integrase Inhibitors
• Entry/Fusion Inhibitors

These drugs work by interfering with different stages of the HIV lifecycle, preventing the virus from replicating and spreading throughout the body. By suppressing the viral load to undetectable levels, ART can prevent the progression of HIV to AIDS and reduce the risk of transmission to others. However, adherence to the prescribed treatment regimen is crucial to maintain viral suppression and prevent the development of drug resistance.

While ART is highly effective, it can also cause side effects such as nausea, fatigue, diarrhea, and other adverse reactions. Regular monitoring and management of side effects by healthcare providers are essential for maintaining treatment adherence and overall health. 6 7

6. Prevention of HIV

Preventing HIV transmission is a crucial public health goal, and several strategies have been developed to reduce the risk of infection.

Safe Sex Practices

• Consistent and correct use of condoms during sexual activity can significantly reduce the risk of HIV transmission.
• Pre- Exposure Prophylaxis (PrEP) is a daily medication regimen that can be taken by HIV-negative individuals at high risk of exposure to reduce their chances of acquiring HIV.
• Post- Exposure Prophylaxis (PEP) is a short-term course of antiretroviral drugs that can be taken within 72 hours after a potential exposure to HIV to prevent infection.

Harm Reduction Strategies

• Needle exchange programs provide clean needles and syringes to intravenous drug users, reducing the risk of HIV transmission through shared needles.
• Safe injection sites offer a supervised, hygienic environment for drug use, reducing the risk of HIV transmission and providing access to health services and counseling.

Mother-to-Child Transmission Prevention

HIV-positive pregnant women can take antiretroviral medications during pregnancy and delivery, and their newborns can receive treatment after birth to significantly reduce the risk of mother-to-child transmission. Avoiding breastfeeding or using safe alternatives is also recommended. 8

7. Living with HIV

Living with HIV can be challenging, both physically and emotionally. Coping with the diagnosis and disclosing one’s status to partners, family, and friends can be difficult and may require support from healthcare providers, counselors, or support groups.

Mental health issues, such as depression and anxiety, are common among people living with HIV and should be addressed as part of a comprehensive care plan. Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and stress management techniques, can improve overall quality of life and help manage the chronic condition.

Support systems, whether through family, friends, or community organizations, can provide invaluable emotional and practical assistance for individuals living with HIV. Additionally, many resources and legal protections are available to ensure access to healthcare, employment, and housing for those affected by HIV. 9

infections”>8. HIV and Co-Infections

Individuals with HIV are at an increased risk of developing certain co- infections and co-morbidities due to their weakened immune systems.

Tuberculosis (TB) and HIV

HIV and tuberculosis (TB) are closely linked, as HIV weakens the immune system and increases the risk of developing active TB disease. Co- infection with HIV and TB can accelerate the progression of both diseases, leading to more severe illness and a higher risk of death.

Hepatitis B and C and HIV

Hepatitis B and C viruses can be transmitted through the same routes as HIV, such as exposure to infected blood or sexual contact. Co- infection with HIV and hepatitis B or C can lead to more rapid liver damage and an increased risk of liver disease progression.

Other Opportunistic Infections

People with advanced HIV infection (AIDS) are at risk of developing various opportunistic infections, such as pneumocystis pneumonia, cytomegalovirus (CMV) infections, toxoplasmosis, and certain types of cancers, due to their weakened immune systems. Early diagnosis and treatment of HIV, as well as prophylactic medications, can help prevent these opportunistic infections. 10

9. HIV in Different Populations

HIV affects various populations differently, and certain groups may face unique challenges or increased risks.

Women and HIV

Women face specific biological, social, and economic factors that can increase their vulnerability to HIV infection. Gender-based violence, lack of access to education and healthcare, and cultural norms can also contribute to higher rates of HIV among women in some regions.

Children and HIV

Children can acquire HIV through mother-to-child transmission during pregnancy, childbirth, or breastfeeding. Early diagnosis and treatment are crucial for improving health outcomes and reducing the risk of transmission to others.

Men who have Sex with Men ( MSM) and HIV

Men who have sex with men ( MSM) represent a significant proportion of new HIV infections globally. Factors such as stigma, discrimination, and lack of access to culturally competent healthcare services can contribute to higher HIV rates among this population.

Intravenous Drug Users and HIV

Sharing needles or other injection equipment among intravenous drug users is a major risk factor for HIV transmission. Harm reduction strategies, such as needle exchange programs and safe injection sites, can help reduce the spread of HIV within this population.

Targeted HIV prevention, testing, and treatment initiatives are essential for addressing the unique needs and challenges faced by these diverse populations. 11

10. Global Impact of HIV/AIDS

HIV/AIDS has had a profound global impact, both in terms of public health and socioeconomic consequences.

Epidemiology and Statistics

According to UNAIDS, as of 2021, approximately 38.4 million people worldwide were living with HIV, with 1.5 million new infections occurring that year. Sub-Saharan Africa remains the region most heavily affected by the HIV/AIDS epidemic.

Socioeconomic Impact

HIV/AIDS has had far-reaching socioeconomic consequences, including increased healthcare costs, reduced productivity, and the loss of skilled workers in various sectors. The epidemic has also exacerbated poverty and inequality in many regions, particularly in low- and middle-income countries.

Public Health Initiatives

Global efforts to address HIV/AIDS have led to the development of various public health initiatives, such as the President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the UNAIDS program. These initiatives aim to improve access to HIV prevention, treatment, and care services worldwide.

International Organizations and HIV Programs

Organizations like the World Health Organization (WHO) an